The DOI matches its Crossref record; 211 of the 213 references it cites were found in a registry or an index.
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Abstract
As the mainstay in the treatment of various cancers, chemotherapy plays a vital role, but still faces many challenges, such as poor tumour selectivity and multidrug resistance (MDR). Targeted drug delivery using nanotechnology has provided a new strategy for addressing the limitations of the conventional chemotherapy. In the last decade, the volume of research published in this area has increased tremendously, especially with functional nano drug delivery systems (nanocarriers). Coupling a specific stimuli-triggered drug release mechanism with these delivery systems is one of the most prevalent approaches for improving therapeutic outcomes. Among the various stimuli, pH triggered delivery is regarded as the most general strategy, targeting the acidic extracellular microenvironment and intracellular organelles of solid tumours. In this review, we discuss recent advances in the development of pH-sensitive nanocarriers for tumour-targeted drug delivery. The review focuses on the chemical design of pH-sensitive biomaterials, which are used to fabricate nanocarriers for extracellular and/or intracellular tumour site-specific drug release. The pH-responsive biomaterials bring forth conformational changes in these nanocarriers through various mechanisms such as protonation, charge reversal or cleavage of a chemical bond, facilitating tumour specific cell uptake or drug release. A greater understanding of these mechanisms will help to design more efficient drug delivery systems to address the challenges encountered in conventional chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Acidic pH caused protonation leads to hydrophilic-hydrophobic phase transition for the anionic polymers, and hydrophobic- hydrophilic phase transition for cationic polymers, inducing deformation of amphiphilic structures leading to drug release [136].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [136]
In the citing paper
“Generally, two basic perceptions define the mechanism of the pH-responsive nanoparticles, such as the cleavage of chemical bonds and nanocarrier protonation.138”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [138]
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
(1989) · PubMed · Cited by 3,343
Thermo- and pH-responsive polymers in drug delivery☆
SCHMALJOHANN, D. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.020 · Cited by 3,023
Danhier, F., Féron, O., & Véronique Préat, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,891
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,198
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
WICKI, A. N., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,962
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Lipid polymorphism and the functional roles of lipids in biological membranes
Cullis, P. R., & KRUIJFF, B. D. (1979) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(79)90012-1 · Cited by 1,865
Flagged first, then by citations
2 of the 213 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Immordino, 2006, Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential, Int. J. Nanomedicine, 1, 297
- Liu, 2014, pH-Sensitive nano-systems for drug delivery in cancer therapy, Biotechnol. Adv., 32, 693, 10.1016/j.biotechadv.2013.11.009 · DOI · Paper page
- Sun, 2014, Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds, Biomaterials, 35, 836, 10.1016/j.biomaterials.2013.10.011 · DOI
- Carmali, 2014, Chapter 13-polyacetals, 219
Cited by
Sorted by citations
Items 501–600 of 1,000
Debele, T. A., Wu, H., Wu, S.-R., Shan, Y., & Su, W. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080778 · Cited by 22
Immunostimulatory biomaterials to boost tumor immunogenicity
Shofolawe-Bakare, O. T., Stokes, L. D., Hossain, M., Smith, A. E., & Werfel, T. A. (2020) · Biomaterials Science · doi:10.1039/d0bm01183e · Cited by 24
Recent Developments in Pathological pH-Responsive Polymeric Nanobiosensors for Cancer Theranostics
Kumar, E. K. P., Um, W., & Park, J. H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.601586 · Cited by 22
Chen, M., Wang, M., Niu, W., Cheng, W., Guo, Y., Wang, Y., Luo, M., Xie, C., Leng, T., Zhang, X., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01337 · Cited by 22
Dynamic covalent chemistry in live cells for organelle targeting and enhanced photodynamic action
Liu, F., Danylchuk, D. I., Andreiuk, B., & Klymchenko, A. S. (2022) · Chemical Science · doi:10.1039/d1sc04770a · Cited by 22
Chen, S., Morrison, G., Liu, W., Kaur, A., & Chen, R. (2022) · Biomaterials Science · doi:10.1039/d2bm01087a · Cited by 24
Heck, A. G., Stickdorn, J., Rosenberger, L. J., Scherger, M., Woller, J., Eigen, K., Bros, M., Grabbe, S., & Nuhn, L. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08511 · Cited by 22
Curcio, M., Mauro, L., Naimo, G. D., Amantea, D., Cirillo, G., Tavano, L., Casaburi, I., Nicoletta, F. P., Alvarez‐Lorenzo, C., & Iemma, F. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.04.057 · Cited by 23
Nanotherapy Targeting the Tumor Microenvironment
Gong, B., Wang, R., Xu, H., Miao, M., & Yao, Z. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009619666181220103714 · Cited by 22
Polymer Nanoplatforms at Work in Prostate Cancer Therapy
He, L., Liu, J., Li, S., Feng, X., Wang, C., Zhuang, X., Ding, J., & Chen, X. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800122 · Cited by 22
Liu, S., Wu, G., Zhang, X., Yu, J., Liu, M., Zhang, Y., Wang, P., Yin, X., Zhang, J., Li, F., et al. (2019) · Journal of the Textile Institute · doi:10.1080/00405000.2019.1610999 · Cited by 22
Li, J., Du, N., Tan, Y. C., Hsu, H., Tan, C., & Jiang, Y. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01564 · Cited by 22
Ma, M., Chen, Y., Zhao, M., Sui, J., Guo, Z., Yang, Y., Xu, Z., Sun, Y., Fan, Y., & Zhang, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120741 · Cited by 22
Dini, C., Borges, M. H. R., Malheiros, S. S., Piazza, R. D., van den Beucken, J. J. J. P., de Ávila, É. D., Souza, J. G. S., & Barão, V. A. R. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402926 · Cited by 21
Advances in stimuli-responsive polymeric hydrogels for anticancer drug delivery: A review
Omer, A. M., El-Monaem, E. M. A., Eltaweil, A. S., Tamer, T. M., Eldin, M. S. M., Ouyang, X., & Heydari, A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106394 · Cited by 21
Guo, X., Mei, J., & Zhang, C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s226517 · Cited by 21
Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy
Wang, W., Fan, J., Zhu, G., Wang, J., Qian, Y., Li, H., Ju, J., & Shan, L. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s247443 · Cited by 21
Sun, Y., Li, Y., Shi, S., & Dong, C. (2021) · Molecules · doi:10.3390/molecules26092703 · Cited by 21
“The most common pH sensitive bonds include hydrazone bond, imine bond, oxime bond, amide bond, benzoic-imine bond, orthoesters, polyacetals, and ketals [151,152].”
BackgroundSudağıdan, M., Yildiz, G., Önen, S., Al, R., Temiz, Ş. N., Yurt, M. N. Z., Taşbaşi, B. B., Acar, E. E., Coban, A., Aydın, A., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126364 · Cited by 21
Setia, A., Sahu, R. K., Ray, S., Widyowati, R., Ekasari, W., & Saraf, S. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220627110049 · Cited by 21
Bagheri, M., Zandieh, M. A., Daryab, M., Samaei, S. S., Gholami, S., Rahmanian, P., Dezfulian, S., Eary, M., Rezaee, A., Rajabi, R., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101838 · Cited by 21
“The mechanism of pH-sensitive bonds can be based on protonable groups or acid-sensitive bonds [124,125].”
BackgroundLi, F., Zhang, Z., Wang, X., Yin, X., Fu, M., Qin, T., Ji, X., Yang, G., & Sun, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138875 · Cited by 22
Hydrogels from Fundaments to Application
Kołodyńska, D., Skiba, A., Górecka, B., & Hubicki, Z. (2016) · InTech eBooks · doi:10.5772/63466 · Cited by 20
“[82] indicate that pH-sensitive hydrogels for tumour-targeted drug delivery have provided a new strategy for addressing the limitations of the conventional chemotherapy, i.”
BackgroundImproving the Efficacy of Anticancer Drugs via Encapsulation and Acoustic Release
Ahmed, S. E., Awad, N. S., Paul, V., Moussa, H. G., & Husseini, G. A. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180608125344 · Cited by 21
“, amines or carboxylic acids) or acid-labile bonds [137].”
BackgroundWang, L., Zhang, C., Li, T., Duan, M., Xia, F., Li, X., Song, C., Pan, S., Liu, B., & Cui, D. (2019) · Nanoscale · doi:10.1039/c9nr07334e · Cited by 21
Self-Monitoring and Self-Delivery of Self-Assembled Fluorescent Nanoparticles in Cancer Therapy
Liu, H., Yuan, M., Liu, Y., Guo, Y., Xiao, H., Guo, L., & Liu, F. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s294279 · Cited by 21
Borges, G. S. M., Lima, F. A., Carneiro, G., Goulart, G. A. C., & Ferreira, L. A. M. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1919619 · Cited by 21
Goh, S. W., Ng, Q. H., Rahim, S. K. E. A., Low, S. C., Hoo, P. Y., Yeo, R. Y. Z., Chew, T. L., & Jawad, Z. A. (2025) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2025.106993 · Cited by 20
Sutradhar, S. C., Banik, N., Bari, G. A. K. M. R., & Jeong, J.-H. (2025) · Gels · doi:10.3390/gels11090761 · Cited by 21
Improved Targeting of Cancers with Nanotherapeutics
Foster, C., Watson, A., Kaplinsky, J., & Kamaly, N. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6646-2_2 · Cited by 20
Lin, J., Zhao, C., Liu, C., Fu, S., Han, L., Lu, X., & Yang, C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s152395 · Cited by 20
Hosseini, S. H., Alipour, S., & Zohreh, N. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b02390 · Cited by 20
Recent advances of smart acid‐responsive gold nanoparticles in tumor therapy
Zhang, Y., Yang, L., Yang, C., & Liu, J. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1619 · Cited by 22
Domiński, A., Domińska, M., Skonieczna, M., Pastuch-Gawołek, G., & Kurcok, P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020290 · Cited by 20
“, by incorporating a sugar unit into the drug structure (glycoconjugation) [26,27] or using pH-sensitive drug carriers [28,29].”
MethodYang, M. M., Yarragudi, S. B., Jamieson, S. M. F., Tang, M., Wilson, W. R., & Wu, Z. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03206-0 · Cited by 23
“Endosomal escape has been long recognized as an important strategy to ensure cytosolic delivery of therapeutics, and several strategies can be employed including pH-responsiveness [12, 13] and “proton sponge effect” pathway [54].”
BackgroundSelf-citationDesign of Nanoparticles in Cancer Therapy Based on Tumor Microenvironment Properties
Firouzabadi, B. M., Gigliobianco, M. R., Joseph, J. M., Censi, R., & Martino, P. D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122708 · Cited by 21
“) to expand the anticancer efficiency [49].”
Nanocarrier‐Based Drug Delivery Systems using Microfluidic‐Assisted Techniques
Alam, M. K. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300041 · Cited by 21
Xia, X., Xiang, X., Huang, F., Zhang, Z., & Han, L. (2017) · Chemical Communications · doi:10.1039/c7cc07615k · Cited by 20
Microchannel system for rate-controlled, sequential, and pH-responsive drug delivery
Yang, D. S., Lee, J. S., Choi, C. K., Lee, H.-P., Cho, S., & Ryu, W. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.12.013 · Cited by 20
Paclitaxel encapsulated in artesunate-phospholipid liposomes for combinatorial delivery
Xia, Q., Ling, L., Ismail, M., Du, Y., He, W., Zhou, W., Yao, C., & Li, X. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.03.010 · Cited by 20
Liang, Y., Zhang, J., Tian, B., Wu, Z., Svirskis, D. M., & Han, J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s226249 · Cited by 20
“Relatively rapid drug release can be achieved inside tumor cells by utilizing intracellular stimuli, such as redox and low pH as a single or dual-trigger.(17,18) For example, biomaterials containing acid-labile bonds such as ester bond can be used to fabricate nanocarriers for targeted drug release to the acidic micro…”
BackgroundSelf-citationHosseini, S. H., Zohreh, N., Karimi, N., Gaeini, N., Alipour, S., Seidi, F., & Gholipour, N. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.040 · Cited by 20
Ramezani-Aliakbari, M., Varshosaz, J., Sadeghi‐Aliabadi, H., Hassanzadeh, F., & Rostami, M. R. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c00623 · Cited by 20
How the Versatile Self‐Assembly in Drug Delivery System to Afford Multimodal Cancer Therapy?
Cao, Y., Zhao, X., Miao, Y., Wang, X., & Deng, D. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202403715 · Cited by 20
Molecular Basis of Na, K–ATPase Regulation of Diseases: Hormone and FXYD2 Interactions
Cordeiro, B. M., Fontes, C. F. L., & Meyer‐Fernandes, J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413398 · Cited by 19
Yang, S.-D., Chen, W., Li, W., Song, J., Gao, Y., & Li, X. (2021) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2021.1884085 · Cited by 19
“The pH responsiveness of the polymer micelles can be triggered by the breakage of the chemical bond in the polymer or via the protonated/deprotonated strategy under the acidic conditions, which led to the disassembly of the micelles and resulted in sharp and complete release of the cargo [20].”
BackgroundWang, R., Sun, Y., He, W., Chen, Y., Lu, E., & Sha, X. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120973 · Cited by 19
Preparation and Drug-Loading Properties of Amphoteric Cassava Starch Nanoparticles
Xie, X., Zhang, Y., Zhu, Y. H., & Lan, Y. (2022) · Nanomaterials · doi:10.3390/nano12040598 · Cited by 19
“It is expected that the drug carriers with amphoteric characteristics will perform good targeting functions [14].”
BackgroundJain, M., Seoud, O. A. E., Kailasa, S. K., & Malek, N. I. (2022) · Journal of Ionic Liquids · doi:10.1016/j.jil.2022.100046 · Cited by 19
pH-sensitive polymeric nanocarriers for enhanced intracellular drug delivery
Pandita, D., Vakar, Poonia, N., Chaudhary, G., Jain, G. K., Lather, V., & Khar, R. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91248-8.00004-0 · Cited by 21
Motta, S., Siani, P., Donadoni, E., Frigerio, G., Bonati, L., & Valentin, C. D. (2023) · Nanoscale · doi:10.1039/d3nr00397c · Cited by 19
Abbasian, M., & Khayyatalimohammadi, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134224 · Cited by 19
Tang, M., Yarragudi, S. B., Pan, P., Yang, K., Kanamala, M., & Wu, Z. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2389969 · Cited by 19
“…due to their endosome escape property. stable at physiological ph ~7.4, Psl destabilizes at acidic ph environment, such as endosomes (ph 5.0–6.5) [5]. subsequently, payloads are released into the cytoplasm allowing drugs to diffuse toward their action target in cells, such as DNa. however, the…”
InfluentialSelf-citationLiu, P., Zheng, H., Yang, Z., Ba, L., Zhu, W., Lin, L., Xiong, Y., Xu, Z., & Ren, J. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00148k · Cited by 19
A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA delivery
Xie, D., Du, J., Bao, M., Zhou, A., Tian, C., Xue, L., Ju, C., Shen, J., & Zhang, C. (2018) · Biomaterials Science · doi:10.1039/c8bm01454j · Cited by 19
Lu, Y., Hou, C., Ren, J., Yang, K., Chang, Y., Pei, Y., Dong, H., & Pei, Z. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s191256 · Cited by 19
Li, H., Fei, C., Yang, D., Tan, C. F., Chen, Z., Wang, J., Wang, G., Fan, H., Yao, H., Wang, C., et al. (2020) · Materials Today Communications · doi:10.1016/j.mtcomm.2020.101383 · Cited by 19
Li, X., Hu, S., Lin, Z. R., Yi, J., Liu, X., Tang, X., Wu, Q., & Zhang, G. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0440 · Cited by 19
Stimuli-responsive nanomaterials for cancer treatment: boundaries, opportunities and applications
Lafuente‐Gómez, N., Latorre, A., Milán-Rois, P., Rodríguez-Díaz, C., & Somoza, Á. (2021) · Chemical Communications · doi:10.1039/d1cc05056g · Cited by 19
Zhu, J., Guo, X., Guo, T., Yang, Y. J., Cui, X., Pan, J., Qu, Y., & Wang, C. (2018) · RSC Advances · doi:10.1039/c8ra07202g · Cited by 19
Ding, Y., Liu, J., Li, X., Xu, L., Li, C., Ma, L., Liu, J., Ma, R., An, Y., Huang, F., et al. (2019) · Materials Chemistry Frontiers · doi:10.1039/c9qm00178f · Cited by 19
Jiang, J., Jin, L., Zhao, Z., Gao, P., Li, M., Zheng, X., & Li, F. (2025) · Nanoscale · doi:10.1039/d5nr02990b · Cited by 18
Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery Systems
Moreno‐Alcántar, G., Picchetti, P., & Casini, A. (2023) · Angewandte Chemie · doi:10.1002/ange.202218000 · Cited by 19
Ghalehkhondabi, V., Soleymani, M., & Fazlali, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130168 · Cited by 18
Dual pH and ultrasound responsive nanocarriers: A smart approach in cancer theranostics
Kaushik, A., Khan, S., Pharasi, N., & Mani, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105560 · Cited by 18
Polymeric prodrug for bio-controllable gene and drug co-delivery
Jia, H., Chen, S., Zhuo, R., Feng, J. X., & Zhang, X. (2016) · Science China Chemistry · doi:10.1007/s11426-016-0230-9 · Cited by 18
Lv, Y., Yang, B., Li, Y., He, F., & Zhuo, R. (2017) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2017.1400146 · Cited by 18
“One of the well-known receptor mediated targeting moieties is folic acid (FA), which has been widely exploited for the tumor-targeting drug delivery because FA-receptors are frequently over-expressed on the surface of human cancer cells [17,18].”
BackgroundIlly, N., Corcé, V., Zimbron, J. M., Molinié, V., Labourel, M., Tresset, G., Degrouard, J., Salmain, M., & Guégan, P. (2019) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201900210 · Cited by 18
Roque, M. C., Franco, M. S., Vilela, J. M. C., Andrade, M. S., de Barros, A. L. B., Leite, E. A., & Oliveira, M. C. (2019) · Current Drug Delivery · doi:10.2174/1567201816666191016112717 · Cited by 18
Ambrogio, M. W., Toro-González, M., Keever, T. J., McKnight, T. E., & Davern, S. M. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c02350 · Cited by 18
Elhassan, E., Omolo, C. A., Gafar, M. A., Ismail, E. A., Ibrahim, U. H., Khan, R. B., Lesouhaitier, M., Kubes, P., & Govender, T. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-024-01114-6 · Cited by 18
Jam, Z. S., Tafvizi, F., Khodarahmi, P., Jafari, P., & Baghbani‐Arani, F. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42685 · Cited by 19
Rajankar, N., Kumar, A., & Gulbake, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107050 · Cited by 20
Yang, H. N., Pan, J., Liang, N., Gong, X.-F., & Sun, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136659 · Cited by 17
“drug and decrease the side effects [9].”
Engineered Hyaluronic Acid-Based Smart Nanoconjugates for Enhanced Intracellular Drug Delivery
Arjama, M., Mehnath, S., Rajan, M., & Jeyaraj, M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.10.005 · Cited by 17
Hassan, I., & Gani, A. (2022) · ACS Food Science & Technology · doi:10.1021/acsfoodscitech.1c00466 · Cited by 17
Bioempowerment of Therapeutic Living Cells by Single‐Cell Surface Engineering
Yang, S., Choi, H., Nguyen, D. T., Kim, N., Rhee, S. Y., Han, S. Y., Lee, H., & Choi, I. S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300037 · Cited by 17
Novel emerging nano-assisted anti-cancer strategies based on the STING pathway
Li, X., Wang, H., Chen, Y., Li, Z., Liu, S., Guan, W., Lin, Y., Cao, C., Zheng, W., & Wu, J. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0023 · Cited by 17
Supramolecular nanotherapeutics based on cucurbiturils
Muheyati, M., Wu, G., Li, Y., Pan, Z., & Chen, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03024-z · Cited by 17
Pradhan, A., Biswal, S., Bhal, S., Biswal, B. K., Kundu, C. N., Subuddhi, U., Pati, A., Hassan, P. A., & Patel, S. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01657 · Cited by 17
Electrospun Nanofibers in Drug Delivery
Agrahari, V., Agrahari, V., Meng, J., & Mitra, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42978-8.00009-7 · Cited by 18
Huang, Y., Gao, Y., Chen, T., Xu, Y., Lu, W. P., Yu, J., Xiao, Y., & Liu, S. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00618 · Cited by 17
Arginine-α, β-dehydrophenylalanine Dipeptide Nanoparticles for pH-Responsive Drug Delivery
Singh, P. K., Chibh, S., Dube, T., Chauhan, V. S., & Panda, J. J. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2299-8 · Cited by 17
Wolski, P., Nieszporek, K., & Pańczyk, T. (2018) · Langmuir · doi:10.1021/acs.langmuir.7b04211 · Cited by 17
Varanda, L. C., de Souza, C. G. S., Perecin, C. J., de Moraes, D. A., de Queiróz, D. F., NEVES, H. R., Souza, J. B., da Silva, M. F., Albers, R. F., & da Silva, T. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818431-8.00004-0 · Cited by 18
Cozens, E. J., Kong, D., Roohpour, N., & Gautrot, J. E. (2019) · Soft Matter · doi:10.1039/c9sm01403a · Cited by 16
Development of 177Lu-DN(C19)-CXCR4 Ligand Nanosystem for Combinatorial Therapy in Pancreatic Cancer
Trujillo-Nolasco, M., Cruz-Nova, P., Ferro‐Flores, G., Gibbens-Bandala, B., Morales-Ávila, E., Aranda‐Lara, L., Vargas, M. A., & Ocampo‐García, B. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3016 · Cited by 17
Deng, Q., Hua, A., Zhao, Q., Zhang, Z., Yang, T., Wang, Q., Yang, X., & Li, Z. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123501 · Cited by 17
Saborit, J. M., Caubet, A., Brissos, R. F., Korrodi‐Gregório, L., Pérez‐Tomás, R., Martı́nez, M., & Gámez, P. (2017) · Dalton Transactions · doi:10.1039/c7dt02127e · Cited by 16
Sun, M., Li, D., Wang, X., He, L., Lv, X., Xu, Y., & Tang, R. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00212j · Cited by 16
pH-responsive micellization of an amine oxide surfactant with branched hydrophobic tail
Scermino, L., Fabozzi, A., Tommaso, G. D., Valente, A. J. M., Iuliano, M., Paduano, L., & D’Errico, G. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113799 · Cited by 16
Mao, W., Wang, S., Mao, D., Liu, Y., Li, L., & Ma, D. (2022) · New Journal of Chemistry · doi:10.1039/d1nj06237a · Cited by 16
Hybrid Biomaterials in Drug Delivery and Biomedical Applications
Ana, I. D. (2022) · Springer eBooks · doi:10.1007/978-981-16-7152-4_15 · Cited by 17
Wu, H., Xu, S., Lin, K., Xu, J., & Fu, D. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104208 · Cited by 16
Study on the Nasal Drug Delivery System of NMD Liposomes In Situ Thermosensitive Gel
Ma, L., Mao, H., Xu, J., Piao, J., & Piao, M. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02679-5 · Cited by 19
“Improved patient compliance, rapid onset of action, minimal systemic exposure, and reduced potential peripheral side effects, in addition to improved drug delivery, offer the possibility of clinical development of dosage forms with multiple benefits for bioavailability in the brain [21–23].”
BackgroundDoxorubicin-triggered self-assembly of native amphiphilic peptides into spherical nanoparticles
Fan, X., Zhao, F., Wang, X., & Wu, G. (2016) · Oncotarget · doi:10.18632/oncotarget.11213 · Cited by 16
“By contrast, acidic pH allows for carboxyl group protonation, causing the structural transformation or disassembly between P45 peptide and Dox because of charge repulsion and consequently leading to the specific release of encapsulated Dox [27, 28].”
BackgroundSong, H., Du, W., Liu, C., Li, Z., Zhang, H., Wei, L., & Yu, M. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.07.009 · Cited by 15
Sun, X., Zhuang, B. A., Zhang, M., Jiang, H., & Jin, Y. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01111 · Cited by 16
Nanoliposomal multi-drug delivery system with reduced toxicity and multi-drug resistance
Yang, J., Wen, C., Pan, C., Guo, H., Zhao, W., Zhang, J., Zhu, Y., Zhang, Y., & Zhang, L. (2019) · Journal of Materials Science · doi:10.1007/s10853-019-03573-x · Cited by 16
Murase, N., Ando, T., & Ajiro, H. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02733e · Cited by 16
Metadata
- Authors
- Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Wu, Zimei
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 85
- Pages
- 152-167
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2288119981
- Cited by
- 1,004
- References
- 213
- Citations by year
- 2026: 65 · 2025: 96 · 2024: 78 · 2023: 85 · 2022: 99 · 2021: 117 · 2020: 129 · 2019: 113 · 2018: 108 · 2017: 77 · 2016: 37
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Royal Society of New Zealand (UOA1201)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- pH-responsive nanocarriers, tumour-targeted drug delivery, stimuli-responsive drug release, intracellular drug release, protonation, charge reversal, bond cleavage, tumor selectivity, multidrug resistance, chemotherapy
- MeSH terms
- Animals, Biocompatible Materials, Clinical Trials as Topic, Disease Models, Animal, Humans, Hydrogen-Ion Concentration, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanostructures, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review